Cato Research and Advanced Targeting Systems partner to develop pain drug
Advanced Pain Therapeutics (APT), a new strategic development company formed by Cato Research, Advanced Targeting Systems (ATS), and Cato BioVentures, the venture capital affiliate of Cato Research, obtained
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.